신신제약: directors' dealings · South Korea · DART (FSS)

Explore the full management transaction log of 신신제약, a listed issuer based in South Korea. Shares are quoted on KR KR, under the oversight of DART (FSS). Operating in the Healthcare sector, 신신제약 has published 2 insider filings. Market capitalisation: €81.5bn. The latest transaction was filed on 11 March 2026 (Other). Among the most active insiders: 신신제약. The full history is free.